Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01230164 · ClinicalTrials.gov registry record
Comparison of Four Different Aberrometers for Evaluation of Higher Order Visual Aberrations
A clinical trial, sponsored by Massachusetts Eye and Ear Infirmary.
- Completed
- Registry status
- 21
- Enrollment target
NCT01230164: Completed study, sponsored by Massachusetts Eye and Ear Infirmary.
NCT01230164 is a clinical trial that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01230164 has completed, sponsored by Massachusetts Eye and Ear Infirmary.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
An aberrometer measures visual aberrations by mapping how light rays travel through the eye and by providing maps using colored gradients to represent the magnitude of refractive errors of the eye. The purpose of this study is to compare 4 different aberrometers -Wavescan (Visx Technology), Zywave (Bausch \& Lomb), Ladarwave aberrometer (Alcon Inc.) and Allegro Analyzer (Alcon Inc). In particular, the investigators propose to focus on the ability of these devices to display the higher order visual aberrations and to compare the quality of outputs from these 4 devices in normal healthy subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-07 |
What the finished NCT01230164 record still lists
NCT01230164 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01230164 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01230164 about?
NCT01230164 is a clinical study titled "Comparison of Four Different Aberrometers for Evaluation of Higher Order Visual Aberrations". An aberrometer measures visual aberrations by mapping how light rays travel through the eye and by providing maps using colored gradients to represent the magnitude of refractive errors of the eye. The purpose of this study is to compare 4 different aberrometers -Wavescan (Visx Technology), Zywave ...
What is the current status of trial NCT01230164?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2010-08. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT01230164?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia